Gastroenterology
|
Takeda Pharmaceuticals Establishes $3 Million Endowment With AGA Foundation
redorbit.com 1 hr ago 2 related
BETHESDA, Md., May 17 /PRNewswire/ -- The American Gastroenterological Association (AGA) Foundation for Digestive Health and Nutrition (FDHN) announced a gift of $3 million from Takeda Pharmaceuticals to establish The Takeda Endowment Fund within the AGA Foundation's overall endowment.
Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48...
biowizard.com 4 hrs ago
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA. OBJECTIVES: Infection with hepatitis C virus (HCV) genotype 6 is common in patients from parts of China and Southeast Asia. No study to date has examined the treatment response to...
National Celiac Awareness Measure Garners Unprecedented Support Industry, Consumers and Policy...
pr.com 2 hrs ago
The American Celiac Disease Alliance (ACDA) announces unprecedented support for bill by Rep. Nita Lowey recognizing May as National Celiac Disease Awareness Month. The measure also emphasizes the important role dietitians play in helping celiac patients, and urges more funding for celiac...
Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at...
redorbit.com 22 hrs ago 2 related
NATICK, Mass., May 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that results from an international, multi-center patient registry documenting the safety and clinical utility of the SpyGlass(R) Direct Visualization System will be presented at Digestive Disease Week(R)...
Nearly 40 Percent of GERD Patients Taking PPIs Experience Recurring Symptoms
prnewswire.com yesterday 4 related
Nearly 40 Percent of GERD Patients Taking PPIs Experience Recurring Symptoms - Despite daily use of doctor-recommended proton pump inhibitors (PPIs) to control gastroesophageal reflux disease (GERD) symptoms, nearly 40 percent of patients who take them continue to experience breakthrough, which...
New Clinical Data on Cellvizio GI to Be Presented At Digestive Disease Week 2008
redorbit.com May 14, 2008 1 related
SAN DIEGO, May 14, 2008 (PRIME NEWSWIRE) -- Mauna Kea Technologies, a leader in in vivo cellular imaging, today announced that one oral presentation and four posters on the company's Cellvizio(r) GI technology will be presented at the Digestive Disease Week(r) (DDW) 2008 conference taking place...
AGI Therapeutics Plc - AGI to Present at DDW
redorbit.com May 15, 2008
5 p.m., Tuesday 20 May, 2008 -- AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality pharmaceutical company focused on gastrointestinal drug products, today announces it will present three poster presentations at Digestive Disease Week (DDW) at the San Diego Convention...
American College Of Gastroenterology And Npg Announce A New Publishing Partnership
medicalnewstoday.com May 14, 2008
The American College of Gastroenterology (ACG) and Nature Publishing Group (NPG) are pleased to announce a new publishing partnership. From January 2009, NPG will publish American Journal of Gastroenterology, the official publication of the ACG. Established in 1934, The American Journal of...
Life Sciences: Study data from College of Medicine update understanding of life sciences
newsrx.com May 14, 2008
Investigators publish new data in the report 'Insights into normal and disordered bowel habits from bowel diaries.' According to recent research from the United States, "While symptom questionnaires provide a snapshot of bowel habits, they may not reflect day-to-day variations or the relationship...
NPS Appoints Dr. Bo Joelsson As Head of Clinical Research
redorbit.com May 13, 2008
Posted on: Tuesday, 13 May 2008, 09:01 CDT NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) announced today the appointment of Bo Joelsson, M.D., Ph.D., as head of clinical research reporting to Alan Harris, M.D., Ph.D., senior vice president R & D and chief medical officer of NPS. One of Dr. Joelsson's...